Edgewise Therapeutics, Inc.
EWTX
$44.17
$0.992.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -57.33M | -49.01M | -50.22M | -40.67M | -36.12M |
| Total Depreciation and Amortization | 597.00K | 590.00K | 575.00K | 570.00K | 567.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.55M | 7.70M | 8.39M | 6.03M | 5.53M |
| Change in Net Operating Assets | 5.71M | -1.82M | 2.66M | -709.00K | -2.56M |
| Cash from Operations | -42.47M | -42.54M | -38.59M | -34.78M | -32.58M |
| Capital Expenditure | -32.00K | -260.00K | -73.00K | -89.00K | -50.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 78.52M | 2.69M | 49.84M | 35.81M | -162.12M |
| Cash from Investing | 78.49M | 2.43M | 49.76M | 35.72M | -162.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.09M | 12.17M | 3.98M | 1.66M | 188.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 38.00K |
| Cash from Financing | 3.09M | 12.17M | 3.98M | 1.66M | 188.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.11M | -27.94M | 15.15M | 2.60M | -6.52M |